In the last trading session, 2.51 million Calidi Biotherapeutics Inc (AMEX:CLDI) shares changed hands as the company’s beta touched 1.05. With the company’s per share price at $0.59 changed hands at -$0.03 or -3.62% during last session, the market valuation stood at $20.49M. CLDI’s last price was a discount, traded about -559.32% off its 52-week high of $3.89. The share price had its 52-week low at $0.20, which suggests the last value was 66.1% up since then. When we look at Calidi Biotherapeutics Inc’s average trading volume, we note the 10-day average is 82.39 million shares, with the 3-month average coming to 14.19 million.
Calidi Biotherapeutics Inc (AMEX:CLDI) trade information
Instantly CLDI was in red as seen at the end of in last trading. With action -21.89%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -68.42%, with the 5-day performance at -21.89% in the red. However, in the 30-day time frame, Calidi Biotherapeutics Inc (AMEX:CLDI) is 91.48% up. Looking at the short shares, we see there were 0.37 million shares sold at short interest cover period of 0.74 days.
The consensus price target for the stock as assigned by Wall Street analysts is 5.5, meaning bulls need an upside of 89.27% from its current market value. According to analyst projections, CLDI’s forecast low is 2 with 9 as the target high. To hit the forecast high, the stock’s price needs a -1425.42% plunge from its current level, while the stock would need to soar -238.98% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for Calidi Biotherapeutics Inc earnings to increase by 84.85%, but the outlook for the next 5-year period is at 53.95% per year.
CLDI Dividends
Calidi Biotherapeutics Inc is expected to release its next quarterly earnings report on 2025-May-14.
Calidi Biotherapeutics Inc (AMEX:CLDI)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 6.81% of Calidi Biotherapeutics Inc shares while 17.24% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 18.50%. There are 17.24% institutions holding the Calidi Biotherapeutics Inc stock share, with RED WAVE INVESTMENTS LLC the top institutional holder. As of 2024-06-30, the company held 1.1723% of the shares, roughly 0.62 million CLDI shares worth $0.12 million.
CPR INVESTMENTS INC. holds the second largest percentage of outstanding shares, with 1.0511% or 0.56 million shares worth $0.11 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 353.38 shares estimated at $0.21 million under it, the former controlled 0.97% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.39% of the shares, roughly 141.47 shares worth around $83976.0.
